MP Current Ratio Analysis
Updated 59h ago·SEC filings & market data
Key Takeaway
The current ratio measures a company’s ability to cover short-term obligations with short-term assets, and at 9.51x, MP holds $9.51 in current assets for every $1 of current liabilities due within a year.
Sector Performance
97th percentileMP
9.51x
Sector Median
1.26x
Sector Avg
2.60x
Prior Period
7.18x(Aug 2026)
Deep Analysis
The current ratio measures a company’s ability to cover short-term obligations with short-term assets, and at 9.51x, MP holds $9.51 in current assets for every $1 of current liabilities due within a year.
This is far above the sector median of 1.26x, placing MP in the 97th percentile among peers and indicating a liquidity cushion that most competitors do not have. The ratio rose 32.5% quarter over quarter from 7.18x, reflecting a sharp, recent build-up in liquid assets relative to short-term debts. A high and increasing current ratio reduces near-term solvency risk, but it can also suggest that cash is sitting idle rather than being invested for growth. This metric supports the overall CAUTIOUS verdict: the balance sheet is safe from liquidity distress, yet the growing cash pile does not resolve questions about how the company plans to generate returns on that capital.
Frequently Asked Questions
What does the Current Ratio tell investors about MP?
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
How is the Current Ratio calculated?
Current Ratio is calculated as: Current Assets / Current Liabilities.
Learn More About Current Ratio
The Formula
Current Assets / Current Liabilities
Why It Matters
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
Master MP's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MP research report →MP
9.51x
Sector Median
1.26x
Sector Avg
2.60x
How MP's Current Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.